Company Filing History:
Years Active: 2025
Title: Carolina Sánchez Fernández: Innovator in Therapeutic Solutions
Introduction
Carolina Sánchez Fernández is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for autoimmune and inflammatory diseases. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving patient care.
Latest Patents
Carolina holds a patent for "Etanercept variants with improved therapeutical effect." This invention provides improved Etanercept variants that include specific amino acid substitutions, namely A105E and A105E/L106F. These variants are designed to inhibit TNF activity while avoiding the neutralization of human LTα (hLTα). The proposed variants present a promising alternative for clinical use in treating autoimmune or inflammatory diseases, as they mitigate the side effects associated with the original Etanercept molecule while maintaining TNF blocking activity.
Career Highlights
Carolina is affiliated with the Consejo Superior de Investigaciones Científicas, where she continues to advance her research and innovation in the field. Her work is characterized by a commitment to scientific excellence and a focus on developing effective therapeutic options for patients.
Collaborations
Some of her notable coworkers include Antonio Alcami Pertejo and Sergio Martín Pontejo. Their collaborative efforts contribute to the ongoing research and development initiatives within their institution.
Conclusion
Carolina Sánchez Fernández exemplifies the spirit of innovation in biotechnology through her groundbreaking work on Etanercept variants. Her contributions are poised to make a significant impact on the treatment of autoimmune and inflammatory diseases, showcasing the importance of research and development in improving healthcare outcomes.